Due to an ability to improve the amount of CTLs to the tumor and prevent the development of tumor associated CD8 T cell dysfunction, FOLFOX may be highly effective in combination with CAR-T cell and adoptive cell transfer (ACT) therapy. This evidence concerns the gene CD8A and neoplasm.